{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:03:54Z","timestamp":1784253834752,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Proced Online"],"DOI":"10.1186\/s12575-026-00346-0","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T05:26:00Z","timestamp":1779513960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting Hyaluronan Signaling Overcomes Primary Effusion Lymphoma Cells Resistance to Rapamycin"],"prefix":"10.1186","volume":"28","author":[{"given":"Jungang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyu","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"18","key":"346_CR1","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","volume":"332","author":"E Cesarman","year":"1995","unstructured":"Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332(18):1186\u201391.","journal-title":"N Engl J Med"},{"issue":"5","key":"346_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1634\/theoncologist.12-5-569","volume":"12","author":"YB Chen","year":"2007","unstructured":"Chen YB, Rahemtullah A, Hochberg E. Primary effusion lymphoma. Oncologist. 2007;12(5):569\u201376.","journal-title":"Oncologist"},{"issue":"7","key":"346_CR3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrc1391","volume":"4","author":"BP Toole","year":"2004","unstructured":"Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer. 2004;4(7):528\u201339.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"346_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.drup.2008.04.002","volume":"11","author":"BP Toole","year":"2008","unstructured":"Toole BP, Slomiany MG. Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance. Drug Resist Updat. 2008;11(3):110\u201321.","journal-title":"Drug Resist Updat"},{"issue":"24","key":"346_CR5","doi-asserted-by":"publisher","first-page":"25745","DOI":"10.1074\/jbc.M313319200","volume":"279","author":"J Lesley","year":"2004","unstructured":"Lesley J, Gal I, Mahoney DJ, et al. TSG-6 modulates the interaction between hyaluronan and cell surface CD44. J Biol Chem. 2004;279(24):25745\u201354.","journal-title":"J Biol Chem"},{"issue":"10","key":"346_CR6","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/leu.2011.144","volume":"25","author":"Z Qin","year":"2011","unstructured":"Qin Z, Dai L, Bratoeva M, Slomiany MG, Toole BP, Parsons C. Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma. Leukemia. 2011;25(10):1598\u2013609.","journal-title":"Leukemia"},{"issue":"5","key":"346_CR7","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1182\/blood-2006-06-028092","volume":"109","author":"SH Sin","year":"2007","unstructured":"Sin SH, Roy D, Wang L, et al. Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. Blood. 2007;109(5):2165\u201373.","journal-title":"Blood"},{"key":"346_CR8","doi-asserted-by":"crossref","unstructured":"Caro-Vegas C, Bailey A, Bigi R, Damania B, Dittmer DP. Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma. mBio 2019;10(1).","DOI":"10.1128\/mBio.02871-18"},{"issue":"24","key":"346_CR9","doi-asserted-by":"publisher","first-page":"7593","DOI":"10.1158\/1078-0432.CCR-09-2317","volume":"15","author":"MG Slomiany","year":"2009","unstructured":"Slomiany MG, Dai L, Tolliver LB, Grass GD, Zeng Y, Toole BP. Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides. Clin Cancer Res. 2009;15(24):7593\u2013601.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"346_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.canlet.2015.03.034","volume":"362","author":"L Dai","year":"2015","unstructured":"Dai L, Chen Y, Toole B, Parsons C, Qin Z. Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients. Cancer Lett. 2015;362(2):158\u201366.","journal-title":"Cancer Lett"},{"issue":"10","key":"346_CR11","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/leu.2009.117","volume":"23","author":"P Gasperini","year":"2009","unstructured":"Gasperini P, Tosato G. Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma. Leukemia. 2009;23(10):1867\u201374.","journal-title":"Leukemia"},{"issue":"2","key":"346_CR12","doi-asserted-by":"publisher","first-page":"e90349","DOI":"10.1371\/journal.pone.0090349","volume":"9","author":"L Dai","year":"2014","unstructured":"Dai L, Trillo-Tinoco J, Bai L, et al. Systematic analysis of a xenograft mice model for KSHV+ primary effusion lymphoma (PEL). PLoS ONE. 2014;9(2):e90349.","journal-title":"PLoS ONE"},{"issue":"21","key":"346_CR13","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1200\/JCO.2003.06.013","volume":"21","author":"C Simonelli","year":"2003","unstructured":"Simonelli C, Spina M, Cinelli R, et al. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. J Clin Oncol. 2003;21(21):3948\u201354.","journal-title":"J Clin Oncol"},{"issue":"18","key":"346_CR14","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/00002030-199912240-00021","volume":"13","author":"ME Valencia","year":"1999","unstructured":"Valencia ME, Martinez P, Moreno V, Laguna F, Lahoz JG. AIDS-related body cavity-based lymphomas, herpesvirus-8 and HIV infection: a study of seven cases. AIDS. 1999;13(18):2603\u20135.","journal-title":"AIDS"},{"issue":"19","key":"346_CR15","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1200\/JCO.2005.07.084","volume":"23","author":"E Boulanger","year":"2005","unstructured":"Boulanger E, Gerard L, Gabarre J, et al. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol. 2005;23(19):4372\u201380.","journal-title":"J Clin Oncol"}],"container-title":["Biological Procedures Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12575-026-00346-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-026-00346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-026-00346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:27:42Z","timestamp":1784251662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12575-026-00346-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["346"],"URL":"https:\/\/doi.org\/10.1186\/s12575-026-00346-0","relation":{},"ISSN":["1480-9222"],"issn-type":[{"value":"1480-9222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal protocols were approved by the University of Arkansas for Medical Sciences Animal Care and Use Committee (No. 3960) in accordance with national guidelines.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31"}}